Apollo Hospitals Enterprise Limited has scheduled its 45th Annual General Meeting (AGM) for Tuesday, August 25, 2026, to secure shareholder approval for the reappointment of Dr. Prathap C Reddy as Executive Chairman and the issuance of Non-Convertible Debentures (NCDs) aggregating up to ₹7,500 million. The meeting, conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM), also aims to ratify a final dividend of ₹10 per share and reappoint independent director Smt. Rama Bijapurkar, ensuring continuity in leadership and capital structure during the proposed demerger of Apollo Healthtech Limited.

The Board of Directors recommended Dr. Reddy’s reappointment for a two-year term from June 25, 2026, to June 24, 2028. His remuneration includes a fixed pay of ₹85.00 million per annum, variable pay linked to Key Performance Indicators (KPIs), and a commission capped at 1% of net profits before tax, with an annual maximum of ₹75 million. The Nomination & Remuneration Committee highlighted his critical role in overseeing the strategic transition associated with the Healthtech demerger.

Capital Raising and Dividend Payout

Shareholders are requested to approve the private placement of secured or unsecured redeemable NCDs up to ₹7,500 million to fund capital expenditure and general corporate purposes. This issuance falls within the company’s overall approved borrowing limit of ₹38,500 million. Specific terms, including coupon rates and redemption periods, will be determined by the Board for future tranches.

The AGM agenda includes confirming the interim dividend of ₹10 per equity share paid on February 27, 2026, and declaring a final dividend of ₹10 per equity share for FY26. The total dividend payout for the year is ₹20 per share, aggregating to ₹2,875.70 million. The record date for the final dividend is Friday, August 14, 2026, with payments due by September 10, 2026.

Director Appointments

Smt. Sangita Reddy and Dr. Prathap C Reddy retire by rotation and are eligible for reappointment. Smt. Rama Bijapurkar is proposed for reappointment as an Independent Director for a second five-year term, commencing November 12, 2026, to November 11, 2031. Her expertise in business strategy is deemed vital as the company focuses on core hospital operations post-demerger.

E-Voting and Participation Details

Remote e-voting commences on Saturday, August 22, 2026, at 9:00 A.M. IST and concludes on Monday, August 24, 2026, at 5:00 P.M. IST. National Securities Depository Limited (NSDL) serves as the authorized agency. Members holding shares as of the cut-off date, Tuesday, August 18, 2026, are eligible to vote. Physical attendance is dispensed with; however, up to 1,000 members may join the VC/OAVM session on a first-come-first-served basis, excluding large shareholders, promoters, and institutional investors who have unrestricted access.

Financial Context

The AGM follows strong financial results for FY26, where consolidated revenue grew 16% to ₹252,285 million and profit after tax rose 33% to ₹20,027 million. Consolidated EBITDA increased 25% to ₹37,693 million. Return on Capital Employed (ROCE) improved from 20% in FY24 to 23.7% in FY26. The company maintains credit ratings of ICRA AAA Stable, CRISIL AA+ Positive, and India Rating IND AA+/Positive.

What the Numbers Show

The decision to raise ₹7,500 million via NCDs alongside a significant dividend payout indicates a balanced approach to capital allocation. While the company generates substantial cash flows, evidenced by the 33% rise in PAT, the debt issuance supports ongoing expansion without diluting equity. The reappointment of key leadership during a major structural change like the Healthtech demerger suggests management prioritizes stability and strategic continuity.

A notable block trade involving apollo hospitals was recorded on the Bombay Stock Exchange (BSE), with the transaction aggregating to ₹44.19 crore. The deal was executed at a price of ₹8,900.00 per share, covering approximately 49,647 shares.

Block Trade Details

The following table summarises the key parameters of the block trade:

Block trades of this scale are typically executed between institutional participants and are carried out outside the regular order book to minimise market impact. The transaction reflects notable activity in Apollo Hospitals shares on the BSE.